86-108
FINALPhiladelphia
76ers
10-71|L10: 1-9
Cleveland
Cavaliers
73-29|L10: 6-4
-
//
Sports
- All Players
- Seasons
Eastern Conference
Western Conference
More
Sign in
Sign in and connect Sleeper to unlock personalized fantasy insights.
Philadelphia 76ers
Cleveland Cavaliers
| # | Team | W-L | Pct | GB |
|---|---|---|---|---|
| 1 | 57-24 | 0.704 | — | |
| 2 |
| Opponent | Date | Result |
|---|---|---|
| 12/18 | L 97-107 | |
| 12/16 |
| 56-26 |
| 0.683 |
| 1.5 |
| 3 | 47-34 | 0.580 | 10.0 |
| 4 | 47-34 | 0.580 | 10.0 |
| 5 | 47-34 | 0.580 | 10.0 |
| 6 | 45-36 | 0.556 | 12.0 |
| 7 | 43-39 | 0.524 | 14.5 |
| 8 | 42-39 | 0.519 | 15.0 |
| 9 | 40-41 | 0.494 | 17.0 |
| 10 | 35-46 | 0.432 | 22.0 |
| 11 | 66-92 | 0.418 | 29.5 |
| 12 | 33-48 | 0.407 | 24.0 |
| 13 | 32-49 | 0.395 | 25.0 |
| 14 | 10-71 | 0.123 | 47.0 |
| 15 | 0-0 | 0.000 | 16.5 |
| 12/14 | L 96-115 |
| 12/13 | L 76-96 |
| 12/11 | L 95-107 |
| Opponent | Date | Result |
|---|---|---|
| 12/17 | W 104-100 | |
| 12/15 | W 89-77 | |
| 12/11 | W 111-76 | |
| 12/8 | W 105-100 | |
| 12/5 | L 84-99 |
| Player | PointsPPG | FG% | 3P% | FT% |
|---|---|---|---|---|
| 17.7 | 51.6% | 1.9% | 56.4% | |
| 14.5 | 40.3% | 30.1% | 51.4% | |
| 13.0 | 37.5% | 32.6% | 53.8% |
| Player | PointsPPG | FG% | 3P% | FT% |
|---|---|---|---|---|
| 25.4 |
| 29.8% |
| 72.3% |
| 21.3 | 44.9% | 33.9% | 79.0% |
| 15.8 | 40.6% | 34.1% | 70.7% |
| Category | CLE Offense | PHI Defense | Advantage |
|---|---|---|---|
Offensive RatingPoints scored per 100 possessions | #390.2 ORtg | #25107.4 DRtg | CLE |
Turnover RateLower offensive turnovers vs defensive forced turnovers | #610.7% | #1314.4% | PHI |
3P% vs AllowedPerimeter efficiency vs perimeter defense | #337.6% | #1936.0% | CLE |
| Category | CLE Defense | PHI Offense | Advantage |
|---|---|---|---|
Offensive RatingPoints allowed per 100 possessions | #11103.6 DRtg | #2781.8 ORtg | PHI |
Turnover RateDefensive takeaways vs offensive giveaways | #1913.4% | #2813.2% | CLE |
3P% vs AllowedPerimeter defense vs perimeter shooting | #1335.2% | #2034.2% | PHI |
